Bifendate Tablets
Function and Efficacy
This product is an intermediate in the synthesis of Schisandra chinensis C. Oral administration of 150-200 mg/kg of this product to mice can reduce liver damage and elevated alanine aminotransferase (ALT) caused by carbon tetrachloride. It has an inhibitory effect on liver microsomal lipid peroxidation caused by carbon tetrachloride and the metabolic conversion of carbon tetrachloride into carbon monoxide, and reduces the consumption of reduced coenzyme II and oxygen in the metabolic process of carbon tetrachloride, thereby protecting the structure and function of the hepatocyte biomembrane. This product can also reduce the elevation of liver ALT induced by prednisone and promote liver regeneration in mice with partial hepatectomy. The enzyme-lowering effect of this product does not directly inhibit the activity of serum and liver ALT, nor does it accelerate the inactivation of ALT in the blood, which may be a reflection of the reduction of liver tissue damage. This product has a significant induction effect on the activity of cytochrome P450 enzymes, thereby enhancing the detoxification ability of carbon tetrachloride and certain carcinogens. It has an effect on improving protein metabolism in some hepatitis patients, increasing albumin and reducing globulin. It has no negative conversion effect on HbsAg and HbeAg, and cannot shrink the enlarged liver and spleen.
Ingredients
Biphenyl diester. Chemical name: 4,4-dimethoxy-5,6,5,6-bis(methylenedioxy)biphenyl-2,2-dicarboxylic acid dimethyl ester. Molecular weight: 418.36 Molecular formula: C20H18O10
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| BifendateIngredients |
This product is an intermediate in the synthesis of Schisandrae Chinensis A, which can reduce liver damage and alanine aminotransferase (ALT) elevation caused by carbon tetrachloride; inhibit liver microsomal lipid peroxidation caused by carbon tetrachloride, its metabolic conversion to carbon monoxide, and reduce the consumption of reduced coenzyme II and oxygen in the metabolic process, thereby protecting the structure and function of liver cell biomembrane; can reduce the increase of liver ALT induced by prednisone, and promote liver regeneration in mice with partial hepatectomy; has a significant induction effect on cytochrome P450 enzyme activity, and enhances the detoxification ability of carbon tetrachloride and certain carcinogens; has an effect on improving protein metabolism in some hepatitis patients, increasing albumin and reducing globulin. However, it has no negative conversion effect on HbsAg and HbeAg, and cannot shrink the enlarged liver and spleen. More |
73536-69-3 | 12 |
Appearance
This product is white tablets.
Indication
This product has a certain effect on the improvement of the main symptoms of hepatitis such as liver pain, fatigue, abdominal distension, etc., but it is ineffective for changes in hepatosplenomegaly. It is suitable for patients with persistent hepatitis and long-term single alanine aminotransferase abnormalities.
Usage and Dosage
Oral administration: 25 mg each time, 75 to 150 mg per day, usually 3 times a day.
Adverse Reactions
In some cases, mild nausea and occasional rash may occur after taking the drug.
Precautions
1. It is contraindicated for those who are allergic to this product; 2. It is contraindicated for those with cirrhosis; 3. It is contraindicated for pregnant and lactating women.
Special Population Medication
Precautions for children: Reduce the dosage for children. Precautions for pregnancy and lactation: Pregnant and lactating women are prohibited. Precautions for the elderly: Elderly patients should use this product with caution.
Drug Interactions
Not yet clear.
Storage
Keep away from light and store in airtight container.
Packaging Specification
25mg
Validity Period
Tentative 24 months
Manufacturer
Dandong Yichuang Pharmaceutical Co., Ltd.
-
Founded in:
2003-12-30 -
Address:
No. 6, Yongxiang Street, Donggang City, Dandong City, Liaoning Province -
Tax NO.:
9121060075578371X5 -
Registered Funds:
7.142857 million yuan -
Website:
-
Email: